|
Volumn 8, Issue 10, 2002, Pages 941-951
|
AMPA receptor antagonists with additional mechanisms of action: New opportunities for neuroprotective drugs?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT;
6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE;
ALTEPLASE;
AMPA RECEPTOR;
AMPA RECEPTOR ANTAGONIST;
ANTICONVULSIVE AGENT;
CASPASE INHIBITOR;
CITICOLINE;
DIZOCILPINE;
EFAPROXIRAL;
ELIPRODIL;
GLUTAMATE RECEPTOR;
GLUTAMATE RECEPTOR ANTAGONIST;
GLYCINE RECEPTOR ANTAGONIST;
LIFARIZINE;
MEXILETINE;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
NEUROPROTECTIVE AGENT;
NIMODIPINE;
NITRIC OXIDE SYNTHASE INHIBITOR;
OXADIAZOLE DERIVATIVE;
PHENYTOIN;
PHOSPHATIDYLCHOLINE;
RECEPTOR SUBTYPE;
SODIUM CHANNEL;
SODIUM CHANNEL BLOCKING AGENT;
TIRILAZAD;
TOPIRAMATE;
UNINDEXED DRUG;
UROKINASE;
[[3,4 DIHYDRO 7 MORPHOLINO 2,3 DIOXO 6 (TRIFLUOROMETHYL) 1(2H) QUINOXALINYL]METHYL]PHOSPHONIC ACID;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
CEREBROVASCULAR ACCIDENT;
CONTROLLED STUDY;
DRUG CLASSIFICATION;
DRUG MECHANISM;
DRUG POTENTIATION;
DRUG RECEPTOR BINDING;
DRUG SCREENING;
DRUG TARGETING;
HUMAN;
HUMAN CELL;
NEUROPROTECTION;
NONHUMAN;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
RAT;
REVIEW;
STROKE;
|
EID: 0036254731
PISSN: 13816128
EISSN: None
Source Type: Journal
DOI: 10.2174/1381612024607135 Document Type: Review |
Times cited : (26)
|
References (55)
|